Literature DB >> 9802560

Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873.

H Nakajima1, K Inoue, T Ikeda, Y Fujinaga, H Sunagawa, K Takeshi, T Ohyama, T Watanabe, K Inoue, K Oguma.   

Abstract

The 16S toxin was purified from a Clostridium botulinum type D strain 1873 (D-1873). Furthermore, the entire nucleotide sequences of the genes coding for the 16S toxin were determined. It became clear that the purified D-1873 16S toxin consists of neurotoxin, nontoxic nonhemagglutinin (NTNH), and hemagglutinin (HA), and that HA consists of four subcomponents, HA1, HA2, HA3a, and HA3b, the same as type D strain CB16 (D-CB16) 16S toxin. The nucleotide sequences of the nontoxic components of these two strains were also found to be identical except for several bases. However, the culture supernatant and the purified 16S toxin of D-1873 showed little HA activity, unlike D-CB16, though the fractions successively eluted after the D-1873 16S toxin peak from an SP-Toyopearl 650S column showed a low level of HA activity. The main difference between D-1873 and D-CB16 HA molecules was the mobility of the HA1 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Therefore it was presumed that the loss of HA activity of D-1873 16S toxin might be caused by the differences of processing HA after the translation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802560     DOI: 10.1111/j.1348-0421.1998.tb02330.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  8 in total

1.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Construction of "Toxin Complex" in a Mutant Serotype C Strain of Clostridium botulinum Harboring a Defective Neurotoxin Gene.

Authors:  Tomonori Suzuki; Thomas Nagano; Koichi Niwa; Masataka Uchino; Motohiro Tomizawa; Yoshimasa Sagane; Toshihiro Watanabe
Journal:  Curr Microbiol       Date:  2016-10-26       Impact factor: 2.188

3.  Characterization of botulinum progenitor toxins by mass spectrometry.

Authors:  Harry B Hines; Frank Lebeda; Martha Hale; Ernst E Brueggemann
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

4.  Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum Type C and D neurotoxins.

Authors:  Hideyuki Arimitsu; Jae-Chul Lee; Yoshihiko Sakaguchi; Yuji Hayakawa; Michiko Hayashi; Miki Nakaura; Hikaru Takai; Song-Nan Lin; Masafumi Mukamoto; Tom Murphy; Keiji Oguma
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

5.  Arrangement of the Clostridium baratii F7 toxin gene cluster with identification of a σ factor that recognizes the botulinum toxin gene cluster promoters.

Authors:  Nir Dover; Jason R Barash; Julianne N Burke; Karen K Hill; John C Detter; Stephen S Arnon
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

6.  Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.

Authors:  Theresa J Smith; Karen K Hill; Brian T Foley; John C Detter; A Christine Munk; David C Bruce; Norman A Doggett; Leonard A Smith; James D Marks; Gary Xie; Thomas S Brettin
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

7.  Molecular Assembly of Clostridium botulinum progenitor M complex of type E.

Authors:  Subramaniam Eswaramoorthy; Jingchuan Sun; Huilin Li; Bal Ram Singh; Subramanyam Swaminathan
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

8.  A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D.

Authors:  Consuelo Garcia-Rodriguez; Shude Yan; Isin N Geren; Kristeene A Knopp; Jianbo Dong; Zhengda Sun; Jianlong Lou; Fraser Conrad; Wei-Hua Wen; Shauna Farr-Jones; Theresa J Smith; Jennifer L Brown; Janet C Skerry; Leonard A Smith; James D Marks
Journal:  Toxins (Basel)       Date:  2021-09-10       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.